Abstract
The HIV (human immunodeficiency virus) attacks the immune system that, if not treated, causes AIDS. It also penetrates the central nervous system and causes HIV-related neurological disorders (HAND). In this study, fullerene C60 is proposed as a nanocarrier for Amprenavir (Amp), an anti-HIV drug. Also, some physicochemical properties of [Amp + C60] nanocomplex and its components have been theoretically investigated. The dipole moment of two components in the discussed complex (7.292 D) predicts that it will be soluble in polar solvents like water. Therefore, the process of drug delivery through the polar media will be feasible. Investigation of the formation energy and reduced density gradient of the discussed complex confirm that its components interact via weak interactions like Van der Waals forces. Thus, the release of the drug into the target tissue can be easily practical. It assumes no damage to Amp will occur. Fullerene, with unique properties as a highly delocalized conjugated π system, has shown high antioxidant capacity. The density of states and charge decomposition analysis revealed significant contribution of fullerene in the discussed complex orbitals. Amp will be preserved against adverse reactions during drug delivery due to the frontier complex orbitals that they are located on the fullerene part. Anti-HIV drugs like Amp are not able to cross the blood–brain barrier (BBB) and prevent HAND. Fullerene C60 may allow Amp to be transported across the BBB due to its small size and hydrophobicity. Examination of the Mulliken charge changes of the involved atoms, electron localization function , natural bond orbital , and electrostatic potential analyses indicate that the application of fullerene will improve the interaction of Amp with the virus protease. The photo-induced electron transfer studies have demonstrated that some electron transfer processes occurred in the discussed complex from Amp to fullerene C60 part. This feature can be utilized for monitoring and detecting the drug during the drug delivery process.
Graphical abstract
Similar content being viewed by others
References
Eric A. Goethe, Naomi R. Kass, Joseph S. Kass, Neurologic Disease in HIV Infection, in Neurological Complications of Infectious Diseases. ed. by M.D. Rodrigo Hasbun (Springer International Publishing, Cham, 2021), pp. 165–197. https://doi.org/10.1007/978-3-030-56084-3_9
A.R.P. Santiago, O. Fernandez-Delgado, A. Gomez, M.A. Ahsan, L. Echegoyen, Fullerenes as key components for low-dimensional (photo) electrocatalytic nanohybrid materials. Angew Chem Int, Ed 60, 122–141 (2021)
P.A. Volberding, S.G. Deeks, Antiretroviral therapy and management of HIV infection. The Lancet 376(9734), 49–62 (2010)
H. Mitsuya, A.K. Ghosh, Development of HIV-1 protease inhibitors, antiretroviral resistance, and current challenges of HIV/AIDS management. Aspartic. Acid. Proteases. as Ther. Targ 45, 245–262 (2010)
D.A. Cobb, N.A. Smith, B.J. Edagwa, J.M. McMillan, Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research. Expert. Opin. Drug. Deliv. 17(9), 1227–1238 (2020)
G. Leonis, T. Steinbrecher, M.G. Papadopoulos, A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and Saquinavir complexes with HIV-1 protease due to flap mutation I50V: A systematic MM–PBSA and thermodynamic integration study. J. Chem. Inf. Model. 53(8), 2141–2153 (2013)
S.L. Letendre, R.J. Ellis, I. Everall, B. Ances, A. Bharti, J.A. McCutchan, Neurologic complications of HIV disease and their treatment. Top. HIV. Med: Publ. Int. AIDS. Soc., USA 17(2), 46 (2009)
R.H. Enting, R.M. Hoetelmans, J.M. Lange, D.M. Burger, J.H. Beijnen, P. Portegies, Antiretroviral drugs and the central nervous system. AIDS 12(15), 1941–1955 (1998)
A. De Luca, B. Ciancio, D. Larussa, R. Murri, A. Cingolani, M. Rizzo, M. Giancola, A. Ammassari, L. Ortona, Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 59(3), 342–347 (2002)
I.A. Neagu, J. Olejarz, M. Freeman, D.I. Rosenbloom, M.A. Nowak, A.L. Hill, Life cycle synchronization is a viral drug resistance mechanism. PLoS Comput. Biol. 14(2), e1005947 (2018)
A. Akhtar, A. Andleeb, T.S. Waris, M. Bazzar, A.-R. Moradi, N.R. Awan, M. Yar, Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J. Control. Release (2020). https://doi.org/10.1016/j.jconrel.2020.11.021
W.C.H.L. Poretsky, W.C. Hembree, Transgender Medicine (Springer, Cham, 2019)
S. Mehmood, J. Marcoux, J. Gault, A. Quigley, S. Michaelis, S.G. Young, E.P. Carpenter, C.V. Robinson, Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24. Nat. Chem. 8(12), 1152–1158 (2016)
S.D. Pawar, C. Freas, I.T. Weber, R.W. Harrison, Analysis of drug resistance in HIV protease. BMC. Bioinform 19(11), 1–6 (2018)
D. Triki, M.E.C. Contreras, D. Flatters, B. Visseaux, D. Descamps, A.-C. Camproux, L. Regad, Analysis of the HIV-2 protease’s adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet. Sci. Rep. 8(1), 1–13 (2018)
P. Simmons, Amprenavir (Agenerase). Res. Initiat. Treat. act: RITA 5(3), 7–10 (1999)
H.W. Kroto, J.R. Heath, S.C. O’Brien, R.F. Curl, R.E. Smalley, C60: Buckminsterfullerene. Nature 318(6042), 162 (1985)
Z. Mirza, S. Karim, In Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges., seminars in cancer biology. Elsevier 69, 226–237 (2021)
S. Gharehyakheh, A. Ahmeda, A. Haddadi, M. Jamshidi, M. Nowrozi, M.M. Zangeneh, A. Zangeneh, Effect of gold nanoparticles synthesized using the aqueous extract of satureja hortensis leaf on enhancing the shelf life and removing Escherichia coli O157: H7 and listeria monocytogenes in minced camel’s meat: the role of nanotechnology in the food industry. Appl. Organomet. Chem. 34(4), e5492 (2020)
J.C. Adkins, D. Faulds, Amprenavir. Drugs 55(6), 837–842 (1998)
R. Partha, J.L. Conyers, Biomedical applications of functionalized fullerene-based nanomaterials. Int. J. Nanomed. 4, 261 (2009)
K. Aschberger, H.J. Johnston, V. Stone, R.J. Aitken, C.L. Tran, S.M. Hankin, S.A. Peters, F.M. Christensen, Review of fullerene toxicity and exposure–appraisal of a human health risk assessment, based on open literature. Regul. Toxicol. Pharmacol. 58(3), 455–473 (2010)
I. Rašović, Water-soluble fullerenes for medical applications. Mater. Sci. Technol. 33(7), 777–794 (2017)
N. Baig, I. Kammakakam, W. Falath, Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater. Adv. 2(6), 1821–1871 (2021)
J.S. Al-Otaibi, Y.S. Mary, Y.S. Mary, S. Kaya, G. Serdaroglu, DFT computational study of trihalogenated aniline derivative’s adsorption onto graphene/fullerene/fullerene-like nanocages, X12Y12 (X= Al, B, and Y= N, P). J. Biomol. Struct. Dyn. (2021). https://doi.org/10.1080/07391102.2021.1914172
M.N. Namivandi, A.A. Taherpour, M. Ghadermazi, M. Jamshidi, Theoretical study on cubane molecule and its reduced states (C8H8n; n= 0 and − 1 to− 4); a first principle DFT study. J. Iran. Chem. Soc. 18(12), 3303–3312 (2021)
S.H. Friedman, D.L. DeCamp, R.P. Sijbesma, G. Srdanov, F. Wudl, G.L. Kenyon, Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115(15), 6506–6509 (1993)
H. Tzoupis, G. Leonis, S. Durdagi, V. Mouchlis, T. Mavromoustakos, M.G. Papadopoulos, Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations. J. Comput. Aided Mol. Des. 25(10), 959–976 (2011)
S. Tanimoto, S. Sakai, S. Matsumura, D. Takahashi, K. Toshima, Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid. Chem. Commun. 44, 5767–5769 (2008)
A. Taherpour, P. Gholami Keivanani, M. Jamshidi, S. Hatami, N. Zolfaghar, Theoretical studies on photo-induced electron transfer process on [Thioridazine] C60 nano-complex; A first principle DFT and TD-DFT. Scientia Iranica 28(3), 1343–1352 (2021)
I.V. Mikheev, M.M. Sozarukova, D.Y. Izmailov, I.E. Kareev, E.V. Proskurnina, M.A. Proskurnin, Antioxidant potential of aqueous dispersions of fullerenes C60, C70, and Gd@ C82. Int. J. Mol. Sci. 22(11), 5838 (2021)
Mikheev, I. V., Sozarukova, M. M., Izmailov, D. Y., Kareev, I. E., Proskurnina, E. V., Proskurnin, M. A.,(2021) In vitro Antioxidant Potential Evaluation of Non-Functionalized Fullerenes and Endofullerene.
L.L. Dugan, D.M. Turetsky, C. Du, D. Lobner, M. Wheeler, C.R. Almli, C.K.-F. Shen, T.-Y. Luh, D.W. Choi, T.-S. Lin, Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. 94(17), 9434–9439 (1997)
M. Pate, S. Jain, AN INCLUSIVE review on novel drug delivery strategies for an effectual delivery of bio-active drug molecules in the treatment of acne. J. Adv. Sci. Res. 11(4–9), 1–15 (2021)
T. Henna, V. Raphey, R. Sankar, V.A. Shirin, H. Gangadharappa, K. Pramod, Carbon nanostructures: the drug and the delivery system for brain disorders. Int. J. Pharm. (2020). https://doi.org/10.1016/j.ijpharm.2020.119701
P. Calvo, B. Gouritin, H. Chacun, D. Desmaële, J. D’Angelo, J.-P. Noel, D. Georgin, E. Fattal, J.P. Andreux, P. Couvreur, Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res. 18(8), 1157–1166 (2001)
K. Minami, J. Song, L.K. Shrestha, K. Ariga, Nanoarchitectonics for fullerene biology. Appl. Mater. Today 23, 100989 (2021)
H. Chen, M.A. Ratner, G.C. Schatz, Time-dependent theory of the rate of photo-induced electron transfer. J. Phys. Chem. C 115(38), 18810–18821 (2011)
K. Gholivand, M. Hosseini, Y. Maghsoud, J. Valenta, A.A. Ebrahimi Valmuzi, A. Owczarzak, M. Kubicki, M. Jamshidi, M. Kahnouji, Relations between structural and luminescence properties of novel lanthanide nitrate complexes with bis-phosphoramidate ligands. Inorg. Chem. 58(9), 5630–5645 (2019)
Sluch, M., Quenching of pyrene fluorescence by fullerene C00 in Langmuir—Blodgett films. 1997;
T.D. Bell, K.P. Ghiggino, K.A. Jolliffe, M.G. Ranasinghe, S.J. Langford, M.J. Shephard, M.N. Paddon-Row, Photoinduced energy and electron transfer in a giant zinc porphyrin− bridge− C60 system. J. Phys. Chem. A 106(43), 10079–10088 (2002)
H. Li, H. Pang, L. Zhang, J. Mao, W. Zhang, J. Jiang, P. Li, Q. Zhang, Ultrasensitive biosensing platform based on luminescence quenching ability of fullerenol quantum dots. RSC. Adv. 11(32), 19690–19694 (2021)
S. Karami, M. Shamsipur, A.A. Taherpour, M. Jamshidi, A. Barati, In situ chromophore doping: a new mechanism for the long-wavelength emission of carbon dots. J. Phys. Chem. C 124(19), 10638–10646 (2020)
R. Patel, Y.P. Singh, Synthesis, structural characterization, DFT studies and in-vitro antidiabetic activity of new mixed ligand oxovanadium (IV) complex with tridentate Schiff base. J. Mol. Struct. 1153, 162–169 (2018)
N.M. O’boyle, A.L. Tenderholt, K.M. Langner, Cclib: a library for package-independent computational chemistry algorithms. J. comput. chem 29(5), 839–845 (2008)
A.A. Taherpour, Z. Shahri, O. Rezaei, M. Jamshidi, T. Fellowes, Adsorption, intercalation and sensing of helium on yttrium functionalized open edge boron nitride: a first principle DFT and TDDFT study. Chem. Phys. Lett. 691, 231–237 (2018)
S. Pathak, E. Cao, M.C. Davidson, S. Jin, G.A. Silva, Quantum dot applications to neuroscience: new tools for probing neurons and glia. J. Neurosci. 26(7), 1893–1895 (2006)
J. Kreuter, R.N. Alyautdin, D.A. Kharkevich, A.A. Ivanov, Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674(1), 171–174 (1995)
L. Domingo, M. Ríos-Gutiérrez, P. Pérez, Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules 21(6), 748 (2016)
R.G. Parr, R.G. Pearson, Absolute hardness: companion parameter to absolute electronegativity. J. Am. Chem. Soc. 105(26), 7512–7516 (1983)
R.G. Parr, L. Szentpály, v., Liu, S., Electrophilicity index. J. Am. Chem. Soc. (1999). https://doi.org/10.1021/ja983494x
Pérez, P., Domingo, L. R., Aizman, A., Contreras, R., (2007) The electrophilicity index in organic chemistry. In Theor. comput. Chem., Elsevier: Vol. 19, pp 139-201
A.A. Taherpour, N. Zolfaghar, M. Jamshidi, J. Jalilian, O. Rezaei, Z. Shahri, Structural distortions of fullerene C60n (n = 0 to − 6) by first principle density functional theory. J. Mol. Struct. 1184, 546–556 (2019)
L.R. Domingo, M.J. Aurell, P. Pérez, R. Contreras, Quantitative characterization of the global electrophilicity power of common diene/dienophile pairs in Diels-Alder reactions. Tetrahedron 58(22), 4417–4423 (2002)
J.-P. Jolivet, Water and Metal Cations in Solution. In Met Oxide Nanostruct. Chem (Oxford. University Press). ISBN-13:9780190928117, November 2020 (2009)
S. Dapprich, G. Frenking, Investigation of donor-acceptor interactions: A charge decomposition analysis using fragment molecular orbitals. J. Phys. Chem. 99(23), 9352–9362 (1995)
M. Emadoddin, A.A. Taherpour, M. Jamshidi, Photo-induced electron transfer of [C60+ Abacavir] nano-complex and feasibility of C60 fullerene application as a chemical shift reagent: a DFT/TD-DFT insights. J. Iran. Chem. Soc. (2021). https://doi.org/10.1007/s13738-021-02360-3
S.I. Gorelsky, E.I. Solomon, Extended charge decomposition analysis and its application for the investigation of electronic relaxation. Theoret. Chem. Acc. 119(1–3), 57–65 (2008)
M. J. Frisch, G. W. T., H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, , Gaussian, Inc., Wallingford CT, Gaussian 09, Revision A.02. 2009.
C.-H. Shen, Y.-F. Wang, A.Y. Kovalevsky, R.W. Harrison, I.T. Weber, Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters. FEBS J 277(18), 3699–3714 (2010)
C. Parlak, Ö. Alver, A density functional theory investigation on amantadine drug interaction with pristine and B, Al, Si, Ga, Ge doped C60 fullerenes. Chem. Phys. Lett. 678, 85–90 (2017)
F. Hassani, H. Tavakol, A DFT, AIM and NBO study of adsorption and chemical sensing of iodine by S-doped fullerenes. Sens. Actuators, B Chem. 196, 624–630 (2014)
A.A. Taherpour, M. Jamshidi, O. Rezaei, DFT and TD-DFT theoretical studies on photo-induced electron transfer process on [Cefamandole].C60 nano-complex. J. Mol. Graph. Model. 75, 42–48 (2017)
M.N. Namivandi, A.A. Taherpour, M. Ghadermazi, M. Jamshidi, Novel donor–acceptor non-fullerene metal–organic solar cells based on open edge Sc@ BN: a DFT and TD-DFT study. J. Iran. Chem. Soc. 18(9), 2271–2282 (2021)
Acknowledgements
We have acknowledged the Theoretical and Computational Research Center of Chemistry Faculty of the Razi University of Kermanshah, Iran.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Emadoddin, M., Taherpour, A.A. & Jamshidi, M. A DFT/TD-DFT study of [Amprenavir + C60] PET nanocomplex: feasibility of C60 fullerene application as a nanocarrier. J IRAN CHEM SOC 19, 4169–4186 (2022). https://doi.org/10.1007/s13738-022-02592-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-022-02592-x